SGN-35

A drug used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma that did not get better with other treatment. It is also being studied in the treatment of other types of lymphoma. SGN-35 is made by combining a monoclonal antibody with an anticancer drug. It binds to a protein called CD30, which is on the surface of some lymphoma cells, and may kill cancer cells. SGN-35 is a type of antibody-drug conjugate. Also called Adcetris and brentuximab vedotin. (NCI Dictionary)

YOU MAY ALSO LIKE

SGN-30

A monoclonal antibody that binds to cells that have the CD30 antigen on their surface, including Hodgkin disease cells and cells from…

SGN-17/19

A substance composed of a monoclonal antibody-enzyme fusion protein (SGN-17), containing a cloned binding region of the L49 monoclonal antibody and the…

SGN-00101

A substance that is being studied in the prevention of cancer. It belongs to the family of drugs called fusion proteins. …

SGMS2 wt Allele

Human SGMS2 wild-type allele is located in the vicinity of 4q25 and is approximately 90 kb in length. This allele, which encodes…

SGMS2 Gene

This gene is involved in cell growth.

SGMS1 wt Allele

Human SGMS1 wild-type allele is located in the vicinity of 10q11.2 and is approximately 319 kb in length. This allele, which encodes…